Protein needs and sources Protein becomes particularly crucial during GLP-1 treatment as it helps preserve muscle mass while losing weight
The meta-analysis of these studies found that omega-3 supplementation reduced the risk of cardiovascular disease in patients with diabetes by 7% (Huang 2023)
Aleniglipron (Structure Therapeutics) is heading into Phase 3 in mid-2026
heart failure, treating chronic gastritis associated with dysfunction of the digestive tract, muscular dystrophy and related diseases, poliomyelitis, cerebral childhood paralysis (relaxation type), progressive spinal muscle atrophy and similar diseases, ear ringing or hearing loss, liver function impairment in chronic gastric inflammation and chronic liver disease with decreased gastrointestinal function, stabilizing the accommodative function in accommodative asthenopia
While other reports exclude that CAC could be regulated by PPAR factors (Indiveri et al., 2011)